Industry News
Adenoma detection rates linked to colorectal cancer and mortality
Apr 02, 2014
A study of over 224,000 patients and more than 314,000 colonoscopies found that adenoma detection rates closely tracked the future risk of colorectal cancer. The study was published in The New England Journal of Medicine.Colonoscopies screen for colorectal cancer by detecting early, curable cancers. Read More
New general concept for the treatment of cancer
Apr 02, 2014
A team of researchers from five Swedish universities, led by Karolinska Institutet and the Science for Life Laboratory, have identified a new way of treating cancer. The concept is presented in the journal Nature and is based on inhibiting a specific enzyme called MTH1, which cancer cells, unlike normal cells, require for survival. Read More
Medication does not help prevent erectile dysfunction following radiation therapy for prostate cancer
Apr 02, 2014
Among men undergoing radiation therapy for prostate cancer, daily use of the erectile dysfunction drug tadalafil, compared with placebo, did not prevent loss of erectile function, according to a study in JAMA. Erectile dysfunction (ED) is a common condition resulting from many causes, including prostate cancer treatment. Read More
Higher risk of death from skin cancer among men living alone
Apr 02, 2014
There are differences in prognosis in cutaneous malignant melanoma depending on cohabitation status and gender, according to a new study published in the scientific periodical Journal of Clinical Oncology. Single men of all ages are more likely to die of their disease.Cutaneous malignant melanoma is the most aggressive form of skin cancer. Read More
New role discovered for enzyme could have implications for cancer and neurologic disease
Apr 02, 2014
Research from Rutgers Cancer Institute of New Jersey shows that a new function discovered for a long-studied enzyme could have implications for the diagnosis and treatment of some cancers and neurological disease. Read More
European commercial launch of first approved life-saving treatment for severe hepatic veno-occlusive disease
Apr 02, 2014
Jazz Pharmaceuticals plc and Gentium S.p.A., a Jazz Pharmaceuticals company, have announced the commencement of the European commercial launch of Defitelio®q (defibrotide), the first licensed product for the treatment of severe hepatic veno-occlusive disease (severe VOD or sVOD) in patients over one month of age undergoing haematopoietic stem cell transplantation (HSCT) therapy. Read More
Administering blood transfusions to patients with lower levels of hemoglobin associated with lower risk of serious infection
Apr 02, 2014
Restricting red blood cell (RBC) transfusions among hospitalized patients to those with hemoglobin (the iron-containing protein in RBCs) measures below a certain level is associated with a lower risk of health care-associated infections, according to a study in JAMA. Efforts to prevent health care-associated infection are among the priorities for the U.S. Read More
Schizophrenia reversed in adolescent mice by experimental cancer drug
Apr 02, 2014
Johns Hopkins researchers say that an experimental anticancer compound appears to have reversed behaviors associated with schizophrenia and restored some lost brain cell function in adolescent mice with a rodent version of the devastating mental illness. Read More
Latest findings reveal the genomic landscape of oesophageal squamous carcinoma
Apr 02, 2014
A team of scientists from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore and National University Cancer Institute Singapore (NCIS), and their collaborators from the Cedars-Sinai Medical Centre, UCLA School of Medicine, demonstrated that a number of novel genetic defects are able to induce oesophageal cancer. Read More
Postsurgery neurofunctional outcome in pediatric spinal tumor improved by early rehabilitation
Apr 02, 2014
In children, primary spinal tumors comprise 4% of all tumors from the central nervous system. Spinal tumors can present with a variety of clinical signs and symptoms in children such as pain followed by motor regression, gait disturbance, sphincter dysfunction, sensory symptoms, torticollis, and kyphoscoliosis. Read More
Previous Page Next Page